Flash Finance

Metropolis Healthcare LimitedMETROPOLISCorporate

Healthcare Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹530.35
MCap ₹11,002 Cr · P/E 63.8
Metropolis Healthcare Limited — Stock analysis & AI research Metropolis Healthcare Limited — Seasonality — best & worst months Metropolis Healthcare Limited — Technical indicators & charts Metropolis Healthcare Limited — Technical setup — score, trend, support & resistance Metropolis Healthcare Limited — Live exchange announcements
📋 High Interest Coverage Stocks📋 Low Debt Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹372 Cr
Sales · Jun 2026
+15.0% YoY
₹94 Cr
Operating Profit · Jun 2026
+21.7% YoY
25.2%
OPM % · Jun 2026
+5.9% YoY
₹51 Cr
Net Profit · Jun 2026
+42.2% YoY
₹2.44
EPS · Jun 2026
-64.5% YoY

📝 Metropolis Healthcare Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Metropolis Healthcare Limited reported revenue of ₹372 crore for the quarter ended June 2026 (Q1 FY27), up 15.0% from ₹324 crore in the same quarter last year, and up 5.8% sequentially over the March 2026 quarter.

Net profit rose 42.2% year-on-year to ₹51 crore, from ₹36 crore. Earnings per share (EPS) came in at ₹2.44.

Operating profit stood at ₹94 crore — an operating margin (OPM) of 25.2%, compared with 23.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Metropolis Healthcare Limited posted revenue of ₹1,366 crore, a growth of 12.3% over FY25, with a net profit of ₹157 crore (up 26.2% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,415 crore with a net profit of ₹172 crore.

Valuation snapshot

At the current price of ₹530.35, METROPOLIS has a market capitalisation of ₹11,002 crore and a trailing P/E of about 63.8.

Within the Healthcare industry, it is the 2nd-largest of the 22 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 48.86%, foreign institutional investors (FIIs) 11.03%, domestic institutional investors (DIIs) 35.12%, public shareholders 4.99% of Metropolis Healthcare Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹11,002 Cr
Current Price ?
₹530.4
P/E ?
63.79above ind
Industry P/E ?
34.70
P/B ?
7.92
P/S ?
7.78
P/FCF ?
38.20
Enterprise Value ?
₹11,184 Cr
EV/EBITDA ?
31.47
PEG ?
12.76
Earnings Yield ?
2.1%
Dividend Yield ?
0.38%
Profitability & Returns
Sales (TTM) ?
₹1,415 Cr
OPM ?
25.1%
Profit after tax (TTM) ?
₹172 Cr
EPS (TTM) ?
₹8.31
ROCE ?
16.0%
ROE ?
12.4%
ROA ?
9.2%
Growth
Sales — latest qtr ?
₹372 Cr
PAT — latest qtr ?
₹51 Cr
YoY qtr sales growth ?
15.0%
YoY qtr profit growth ?
42.2%
Sales growth (3y) ?
9%
Sales growth (5y) ?
11%
Profit growth (3y) ?
5%
Profit growth (5y) ?
-4%
Financial Health
Debt ?
₹182 Cr
Debt to Equity ?
0.13
Interest Coverage ?
11.6
Current Ratio ?
N/A
Ownership
Promoter holding ?
48.86%
Change in promoter holding ?
-0.03%
Pledged percentage ?
N/A
Market
Return 3 months ?
-2.7%
Return 6 months ?
12.4%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 264256285269292286322297312324356335352372 +15.0% +5.8%
Operating Profit 6858675974688265537791809094 +21.7% +4.0%
Other Income 93252343833295 +86.6% -41.2%
Interest 66656554444475 +11.2% -27.3%
Depreciation 2220212425252627272828283328 -0.2% -15.2%
Profit Before Tax 4835423545425537294862426066 +39.2% +11.3%
Net Profit 4026312732314227243647324351 +42.2% +17.0%
EPS 7.805.101.531.306.206.118.245.354.656.879.006.182.092.44 -64.5% +16.7%
OPM % 25.6% 22.7% 23.5% 21.9% 25.3% 23.9% 25.5% 21.9% 16.9% 23.8% 25.7% 23.9% 25.6% 25.2% +5.9% -1.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,217 Cr ₹1,366 Cr ₹1,415 Cr +12.3%
Operating Profit ₹268 Cr ₹339 Cr ₹355 Cr +26.3%
OPM % 22.04% 24.79% 25.12% +12.5%
NPM % 10.26% 11.53% 12.19% +12.4%
Other Income ₹17 Cr ₹16 Cr ₹19 Cr -4.2%
Depreciation ₹105 Cr ₹116 Cr ₹116 Cr +10.8%
Interest ₹18 Cr ₹19 Cr ₹20 Cr +5.1%
EBIT ₹163 Cr ₹223 Cr ₹239 Cr +36.3%
PBT ₹162 Cr ₹212 Cr ₹230 Cr +30.7%
Tax ₹37 Cr ₹54 Cr ₹58 Cr +45.7%
Net Profit ₹125 Cr ₹157 Cr ₹172 Cr +26.2%
EPS ₹24.35 ₹24.14 ₹19.71 -0.9%
Material Cost ₹244 Cr ₹271 Cr ₹274 Cr +10.7%
Employee Cost ₹272 Cr ₹298 Cr ₹311 Cr +9.4%
Extraordinary Items — ₹8 Cr ₹8 Cr —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 10101041 +310.0%
Reserves 9261,0211,2341,348 +9.2%
Borrowings 268195178182 +2.2%
Other Liabilities 230247262299 +14.1%
Total Liabilities 1,4341,4731,6851,870 +11.0%
Fixed Assets 1,0661,1201,1291,135 +0.5%
CWIP 20000 —
Investments 5090321484 +50.8%
Other Assets 299263235252 +7.2%
Total Assets 1,4341,4731,6851,870 +11.0%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 238269275318 +15.6%
Cash from Investing Activity 47-82-196-209 -6.6%
Cash from Financing Activity -288-183-84-111 -32.1%
Net Cash Flow -34-6-2 +66.7%
Free Cash Flow 189209213288 +35.2%
CFO/OP 103%112%113%103% -8.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 43433432 -5.9%
Inventory Days 64564747 +0.0%
Days Payable 133155160166 +3.8%
Cash Conversion Cycle -26-55-79-88 -11.4%
Working Capital Days -15-15-2416 +166.7%
ROCE % 17%15%13%16% +23.1%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 48.89%48.89%48.87%48.86%48.86% +0.0%
FIIs 12.83%12.52%11.68%10.43%11.03% +5.8%
DIIs 32.40%33.10%34.73%35.80%35.12% -1.9%
Public 5.87%5.48%4.69%4.92%4.99% +1.4%
No. of Shareholders 50,01547,84646,67049,17550,636 +3.0%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Metropolis Healthcare Limited's revenue in Q1 FY27?
Metropolis Healthcare Limited reported revenue of ₹372 crore for the quarter ended June 2026 (Q1 FY27), up 15.0% from ₹324 crore in the same quarter last year, and up 5.8% sequentially over the March 2026 quarter.
What was Metropolis Healthcare Limited's net profit in Q1 FY27?
Net profit rose 42.2% year-on-year to ₹51 crore, from ₹36 crore. Earnings per share (EPS) came in at ₹2.44.
What is METROPOLIS's market capitalisation and P/E ratio?
At the current price of ₹530.35, METROPOLIS has a market capitalisation of ₹11,002 crore and a trailing P/E of about 63.8.
Who owns Metropolis Healthcare Limited? (shareholding pattern)
As of Jun 2026, promoters held 48.86%, foreign institutional investors (FIIs) 11.03%, domestic institutional investors (DIIs) 35.12%, public shareholders 4.99% of Metropolis Healthcare Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI